Cutaneous squamous cell carcinoma (cSCC), a non-melanoma skin cancer, is a
keratinocyte carcinoma representing one of the most common cancers with an increasing …

Non-melanoma skin cancer represents one-third of all malignancies and its incidence is
expected to rise until the year 2040. Cutaneous squamous cell carcinoma (cSCC) …

Invasive cutaneous squamous cell carcinoma (cSCC) is one of the most common cancers in
the white populations, accounting for 20% of all cutaneous malignancies. Factors implicated …

Cutaneous squamous cell carcinoma (cSCC) is the second most common cancer, with its
incidence rising steeply. Immunosuppression is a well-established risk factor for cSCC, and …

Skin cancer is a broad term used to describe a number of different malignant indications of
the skin. Skin cancers mostly comprise of the keratinocyte cancers [Basal Cell Carcinoma …

Plasmacytoid dendritic cells (pDCs) are a special subtype of dendritic cells with the
morphology of plasma cells. pDCs produce massive amounts of type I interferon (IFN-I) …

Skin cancer, including melanoma, basal cell carcinoma and cutaneous squamous cell
carcinoma, has one of the highest global incidences of any form of cancer. In 2016 more …

Skin-cancer is the commonest malignancy affecting huge proportion of the population,
reaching heights in terms of morbidity. The treatment strategies are presently focusing on …

Skin cancer is a high burden disease with a high impact on global health. Conventional
therapies have several drawbacks; thus, the development of effective therapies is required …

Cutaneous squamous cell carcinoma represents the second most common cutaneous
malignancy, affecting 7–11% of Caucasians in the United States. The genetic determinants …